-
Subject Areas on Research
-
1,2,4-Trioxanes as potential antimalarial agents.
-
A cross-sectional survey of Plasmodium falciparum pfcrt mutant haplotypes in the Democratic Republic of Congo.
-
ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome.
-
Amodiaquine and sulfadoxine-pyrimethamine as treatment for chloroquine-resistant Plasmodium falciparum in Rwanda.
-
Ataxia telangiectasia-mutated and p53 are potential mediators of chloroquine-induced resistance to mammary carcinogenesis.
-
Autophagy-dependent metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide.
-
Chloroquine improves survival and hematopoietic recovery after lethal low-dose-rate radiation.
-
Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children.
-
Chloroquine, quinine and quinidine inhibit calcium release from macrophage intracellular stores by blocking inositol 1,4,5-trisphosphate binding to its receptor.
-
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.
-
Combining Nelfinavir With Chloroquine Inhibits In Vivo Growth of Human Lung Cancer Xenograft Tumors.
-
Discovery of novel targets of quinoline drugs in the human purine binding proteome.
-
Disruption of lysosome function promotes tumor growth and metastasis in Drosophila.
-
Efficacy of chloroquine on Plasmodium falciparum transmitted at Amani, eastern Usambara Mountains, north-east Tanzania: an area where malaria has recently become endemic.
-
Elimination of malignant clonogenic T cells from human bone marrow using chemoimmunoseparation with 2'-deoxycoformycin, deoxyadenosine and an immunotoxin.
-
Hydroxychloroquine and chloroquine retinopathy: screening for drug toxicity.
-
Hydroxychloroquine as Prophylaxis for Coronavirus SARS-CoV-2 Infection: Review of the Ongoing Clinical Trials.
-
Hydroxychloroquine/chloroquine for the treatment of hospitalized patients with COVID-19: An individual participant data meta-analysis.
-
Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.
-
In vivo and in vitro susceptibility to chloroquine of Plasmodium falciparum in Kinshasa and Mbuji-Mayi, Zaire.
-
Influence of genotype, dose and sex on pruritogen-induced scratching behavior in the mouse.
-
Intracellular trafficking of angiotensin II and its AT1 and AT2 receptors: evidence for selective sorting of receptor and ligand.
-
Kinetic mechanism of quinone oxidoreductase 2 and its inhibition by the antimalarial quinolines.
-
Kinetics of poliovirus uncoating in HeLa cells in a nonacidic environment.
-
Malaria researchers say global fund is buying "useless drug".
-
Malaria: a rising incidence in the United States.
-
Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
-
Parasites and Progress: Ethical Decision-Making and the Santee-Cooper Malaria Study, 1944-49
-
Parasitologic and clinical efficacy of 25 and 50 mg/kg of chloroquine for treatment of Plasmodium falciparum malaria in Rwandan children.
-
Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
-
Regular examinations for toxic maculopathy in long-term chloroquine or hydroxychloroquine users.
-
Regulation of insulin receptors in frog erythrocytes by insulin and concanavalin A. Evidence for discrete classes of insulin binding sites.
-
Response of children with Plasmodium falciparum to chloroquine and development of a national malaria treatment policy in Zaire.
-
Retinal nerve fibre layer thickness measurements in patients using chloroquine.
-
Synthesis and preliminary evaluation of n.c.a. iodoquine: a novel radiotracer with high uptake in cells with high ALDH1 expression.
-
TNF-α/TNFR1 Signaling is Required for the Full Expression of Acute and Chronic Itch in Mice via Peripheral and Central Mechanisms.
-
Targeting lysosomal degradation induces p53-dependent cell death and prevents cancer in mouse models of lymphomagenesis.
-
The changing landscape of Plasmodium falciparum drug resistance in the Democratic Republic of Congo.
-
The effects of chloroquine on chick skeletal muscle in vitro.
-
The next opportunity in anti-malaria drug discovery: the liver stage.
-
Treatment of erythrocytes with the 2-cys peroxiredoxin inhibitor, Conoidin A, prevents the growth of Plasmodium falciparum and enhances parasite sensitivity to chloroquine.
-
Keywords of People